Activating mutations in CTNNB1 in aldosterone producing adenomas

Scientific Reports
Tobias ÅkerströmPeyman Björklund

Abstract

Primary aldosteronism (PA) is the most common cause of secondary hypertension with a prevalence of 5-10% in unreferred hypertensive patients. Aldosterone producing adenomas (APAs) constitute a large proportion of PA cases and represent a surgically correctable form of the disease. The WNT signaling pathway is activated in APAs. In other tumors, a frequent cause of aberrant WNT signaling is mutation in the CTNNB1 gene coding for β-catenin. Our objective was to screen for CTNNB1 mutations in a well-characterized cohort of 198 APAs. Somatic CTNNB1 mutations were detected in 5.1% of the tumors, occurring mutually exclusive from mutations in KCNJ5, ATP1A1, ATP2B3 and CACNA1D. All of the observed mutations altered serine/threonine residues in the GSK3β binding domain in exon 3. The mutations were associated with stabilized β-catenin and increased AXIN2 expression, suggesting activation of WNT signaling. By CYP11B2 mRNA expression, CYP11B2 protein expression, and direct measurement of aldosterone in tumor tissue, we confirmed the ability for aldosterone production. This report provides compelling evidence that aberrant WNT signaling caused by mutations in CTNNB1 occur in APAs. This also suggests that other mechanisms that constitutive...Continue Reading

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
May 1, 1985·Clinical and Experimental Pharmacology & Physiology·S M HamletR D Gordon
Dec 1, 1966·Cancer·A M Neville, T Symington
Dec 1, 1994·Developmental Biology·J Klingensmith, R Nusse
Oct 1, 1996·Genome Research·C A HeidP M Williams
Nov 30, 2002·European Journal of Endocrinology·F FalloJ M Mathis
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Marie-Hélène BernardChristine Gicquel
Jan 1, 1964·American Journal of Surgery·J W CONNR M NESBIT
Mar 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Paolo MulateroWilliam F Young
Apr 20, 2005·Journal of the American College of Cardiology·Paul MilliezJean-Jacques Mourad
Jun 9, 2005·The Journal of Clinical Endocrinology and Metabolism·Michael StowasserThomas H Marwick
Dec 13, 2006·Journal of the American College of Cardiology·Gian Paolo RossiUNKNOWN PAPY Study Investigators
Apr 27, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Roberto FogariAmedeo Mugellini
Apr 28, 2007·Biochemical and Biophysical Research Communications·Danuta WawrzakLuc Leyns
Jun 17, 2008·The Journal of Clinical Endocrinology and Metabolism·John W FunderUNKNOWN Endocrine Society
Jul 8, 2008·Acta Biochimica Et Biophysica Sinica·Xi ChenChunming Liu
May 14, 2011·The Journal of Clinical Endocrinology and Metabolism·Julien DurandIsabelle Bourdeau
Mar 23, 2012·Cold Spring Harbor Perspectives in Biology·Paul Polakis
Jul 18, 2012·The American Journal of Pathology·Joanne H HeatonGary D Hammer
Aug 6, 2013·Nature Genetics·Elena A B AzizanMorris J Brown
Dec 12, 2013·Molecular and Cellular Endocrinology·Celso E Gomez-SanchezElise P Gomez-Sanchez
Feb 28, 2014·The New England Journal of Medicine·Felix BeuschleinBruno Allolio
Apr 2, 2014·The Journal of General Physiology·Natascia Vedovato, David C Gadsby
Apr 22, 2014·Nature Genetics·Gerald GohRichard P Lifton
Apr 25, 2014·The Journal of Clinical Endocrinology and Metabolism·T DekkersB Küsters
May 29, 2014·Hypertension·Fabio Luiz Fernandes-RosaMaria-Christina Zennaro
May 11, 2015·Molecular and Cellular Endocrinology·Silvia MonticonePaolo Mulatero

❮ Previous
Next ❯

Citations

Apr 14, 2016·The New England Journal of Medicine·Ada E D Teo, Morris J Brown
May 4, 2016·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Valentina CrudoPaolo Mulatero
Jul 30, 2016·Frontiers in Endocrinology·Felicia LecciaAntoine Martinez
Aug 4, 2016·Endocrine-related Cancer·Ravi Kumar DuttaOliver Gimm
Nov 18, 2016·The Tohoku Journal of Experimental Medicine·Yasuhiro NakamuraHironobu Sasano
Nov 20, 2016·Acta Physiologica·S Bandulik
Apr 13, 2017·Journal of Molecular Endocrinology·Fabio Luiz Fernandes-RosaMaria-Christina Zennaro
Mar 14, 2018·American Journal of Hypertension·Ryo MorimotoFumitoshi Satoh
Feb 13, 2018·Current Opinion in Endocrinology, Diabetes, and Obesity·Maria-Christina ZennaroSheerazed Boulkroun
Oct 14, 2017·Current Opinion in Oncology·Norman G NicolsonTobias Carling
May 15, 2018·Clinical Endocrinology·Silvia MonticonePaolo Mulatero
Jul 28, 2017·Endocrine-related Cancer·Masanori MurakamiYoshihiro Ogawa
Oct 5, 2017·Hypertension·Elke Tatjana Aristizabal PradaTracy Ann Williams
Sep 28, 2017·Hypertension·Teresa M SecciaGian Paolo Rossi
Aug 8, 2018·The Journal of Clinical Endocrinology and Metabolism·Kazutaka NanbaWilliam E Rainey
Aug 8, 2018·The Journal of Clinical Endocrinology and Metabolism·Kang-Yung PengKwan-Dun Wu
Oct 19, 2016·Hypertension·Yoko YoshiiMasayasu Yoneda
Jan 30, 2019·Genes & Development·Kaitlin J BashamGary D Hammer
Feb 12, 2019·Hypertension·Kazutaka NanbaWilliam E Rainey
Feb 13, 2019·Endocrine-related Cancer·Antonio M LerarioTobias Else
Jul 23, 2019·Hypertension·John W Funder
Sep 29, 2017·Endocrinology and Metabolism·Jian Jhong WangKwan Dun Wu
Nov 11, 2019·Der Pathologe·U Scholl
Dec 4, 2019·The Journal of Clinical Endocrinology and Metabolism·Yoshikiyo OnoHironobu Sasano
Nov 5, 2016·The Journal of Clinical Endocrinology and Metabolism·Julien VouillarmetMaria-Christina Zennaro
May 5, 2018·The Journal of Clinical Endocrinology and Metabolism·Nadia GagnonIsabelle Bourdeau
Jun 10, 2020·The Journal of Clinical Endocrinology and Metabolism·Zeng GuoMichael Stowasser
Aug 28, 2017·Clinical Chemistry and Laboratory Medicine : CCLM·Sofia M DickSandra P Silveiro
Jan 20, 2018·European Journal of Endocrinology·Silvia MonticonePaolo Mulatero
Nov 7, 2019·Experimental & Molecular Medicine·Eric SeidelUte I Scholl
Dec 31, 2019·Endocrinology and Metabolism·Sergei G TevosianHans K Ghayee
Mar 3, 2020·Hypertension·Kelly De SousaMaria-Christina Zennaro
Jul 30, 2020·Nature Reviews. Endocrinology·Maria-Christina ZennaroFabio L Fernandes-Rosa
Oct 27, 2017·Endocrinology·Leticia Aragao-SantiagoTracy Ann Williams
Mar 16, 2018·Endocrine Pathology·Ozgur MeteMarco Volante
Oct 4, 2017·Endocrine Reviews·Maria-Christina ZennaroFabio Fernandes-Rosa
Apr 14, 2016·The New England Journal of Medicine·Annabel BerthonPierre Val
Sep 10, 2017·Physiological Genomics·Eric Seidel, Ute I Scholl
Apr 13, 2018·International Journal of Molecular Sciences·Elke Tatjana Aristizabal PradaTracy A Williams

❮ Previous
Next ❯

Methods Mentioned

BETA
exome sequencing
ubiquitination
PCR

Software Mentioned

AxioVision SE64

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.